by Paul Haskins | Aug 18, 2012 | Reverse Diabetes
THERE was a time when Jason Whiter couldn’t walk to the shops without feeling like he was going to pass out. But things are looking better for the Ascot Vale real estate agent, who is now working about 60 hours a week. Mr Whiter, 34, was diagnosed with type 1...
by Paul Haskins | Aug 17, 2012 | Reverse Diabetes
What we do: JDRF, or the Juvenile Diabetes Research Foundation, is the leading global organization focused on Type 1 diabetes research. Our research mission is to discover, develop and deliver advances that cure, better treat and prevent Type 1 diabetes. Diabetes is...
by Paul Haskins | Aug 17, 2012 | Reverse Diabetes
By Sharon Begley NEW YORK (Reuters) – A controversial experimental cure for type 1 diabetes, using a tuberculosis vaccine invented a century ago, appears to temporarily vanquish the disease, according to a study in a handful of patients led by a scientist long...
by Paul Haskins | Aug 16, 2012 | Reverse Diabetes
South San Francisco—The FDA has approved once-monthly, 0.3-mg ranibizumab injection (Lucentis, Genentech) for treatment of diabetic macular edema (DME), making it the first and only drug approved by the agency for the condition. The standard of care for DME for the...
by Paul Haskins | Aug 15, 2012 | Reverse Diabetes
Jamie Condliffe View Profile Email Facebook Twitter RSS You’ve maybe never heard of Bacillus Calmette–Guérin—it sounds kinda French after all, so why would you? But scratch a little deeper and you’ll find that BCG, as it’s commonly known, is one of...
